{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:48:10Z","timestamp":1791488890296,"version":"4.3.4"},"reference-count":55,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Cryptococcosis is an invasive fungal infection found worldwide that causes significant morbidity and mortality among a broad range of hosts. There are approximately 223,000 new cases of cryptococcosis annually throughout the world, and at least 180,000 deaths are attributed to this infection each year. Most of these are due to complications of cryptococcal meningoencephalitis among HIV-infected patients in resource-limited environments. The majority of individuals diagnosed with cryptococcosis have underlying conditions associated with immune dysfunction such as HIV, solid organ transplant, hematologic malignancy, organ failure syndromes, and\/or the use of immunosuppressive agents such as glucocorticosteroids and biologic agents. In most clinical series, there is a small proportion of patients with cryptococcosis who are phenotypically normal; that is, they have no clinically obvious predisposition to disease. Cryptococcal meningoencephalitis (CME) presentation and management differ substantially between these normal individuals and their immunocompromised counterparts. In this review, we will focus on CME in the phenotypically normal host and underscore differences in the clinical presentation, management, outcome, and potential risk factors for these patients compared to immunocompromised persons who develop this potential devastating invasive fungal infection.<\/jats:p>","DOI":"10.3390\/pathogens12111303","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T11:16:27Z","timestamp":1698750987000},"page":"1303","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cryptococcal Meningoencephalitis in Phenotypically Normal Patients"],"prefix":"10.3390","volume":"12","author":[{"given":"Pia M.","family":"Cumagun","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Katherine","family":"Moore","sequence":"additional","affiliation":[{"name":"School of Medicine, University of South Alabama, Mobile, AL 35233, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd P.","family":"McCarty","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"McGwin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, University of Alabama, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Pappas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, The University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","article-title":"Cryptococcosis","volume":"30","author":"Maziarz","year":"2016","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.idc.2021.03.012","article-title":"Cryptococcosis","volume":"35","author":"Gushiken","year":"2021","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/322597","article-title":"Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy","volume":"33","author":"Pappas","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3109\/13693780903437876","article-title":"Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997\u20132007","volume":"48","author":"Zhu","year":"2010","journal-title":"Med. Mycol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/587667","article-title":"Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy","volume":"46","author":"Kambugu","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Brizendine, K.D., Baddley, J.W., and Pappas, P.G. (2013). Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060431"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: Implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","article-title":"Recognition of seven species in the Cryptococcus gattii\/Cryptococcus neoformans species complex","volume":"78","author":"Hagen","year":"2015","journal-title":"Fungal Genet. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/CMR.00126-13","article-title":"Cryptococcus gattii infections","volume":"27","author":"Chen","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/cid\/ciab268","article-title":"MSG07: An International Cohort Study Comparing Epidemiology and Outcomes of Patients with Cryptococcus neoformans or Cryptococcus gattii Infections","volume":"73","author":"Baddley","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3201\/eid1602.090900","article-title":"Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999\u20132007","volume":"16","author":"Galanis","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lockhart, S.R., Iqbal, N., Harris, J.R., Grossman, N.T., DeBess, E., Iqbal, N., Harris, J.R., Grossman, N.T., DeBess, E., and Wohrle, R. (2013). Cryptococcus gattii in the United States: Genotypic Diversity of Human and Veterinary Isolates. PLoS ONE, 8.","DOI":"10.1371\/annotation\/c7250cbd-4c85-423a-8b09-da596a72f830"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/S1473-3099(22)00499-6","article-title":"The global burden of HIV-associated cryptococcal infection in adults in 2020: A modelling analysis","volume":"22","author":"Rajasingham","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11046-011-9473-z","article-title":"Ten challenges on Cryptococcus and cryptococcosis","volume":"173","author":"Casadevall","year":"2012","journal-title":"Mycopathologia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/0003-4819-132-3-200002010-00006","article-title":"Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient","volume":"132","author":"Nosanchuk","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2796.2005.01466.x","article-title":"Zoonotic transmission of Cryptococcus neoformans from a magpie to an immunocompetent patient","volume":"257","author":"Lagrou","year":"2005","journal-title":"J. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM197804132981506","article-title":"Cryptococcal endophthalmitis after corneal transplantation","volume":"298","author":"Beyt","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1093\/cid\/ciq216","article-title":"Transmission of Cryptococcus neoformans by Organ Transplantation","volume":"52","author":"Baddley","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e12836","DOI":"10.1111\/tid.12836","article-title":"A cluster of donor-derived Cryptococcus neoformans infection affecting lung, liver, and kidney transplant recipients: Case report and review of literature","volume":"20","author":"Camargo","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"ref_20","first-page":"61","article-title":"Cryptococcal infections in non-HIV-infected patients","volume":"124","author":"Pappas","year":"2013","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"ref_21","first-page":"20499361211004367","article-title":"Increased mortality associated with uncontrolled diabetes mellitus in patients with pulmonary cryptococcosis: A single US cohort study","volume":"8","author":"Archuleta","year":"2021","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1086\/314606","article-title":"Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group","volume":"179","author":"Hajjeh","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","article-title":"Cryptococcal meningitis: Epidemiology, immunology, diagnosis and therapy","volume":"13","author":"Williamson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/cid\/cis529","article-title":"Clinical manifestations of Cryptococcus gattii infection: Determinants of neurological sequelae and death","volume":"55","author":"Chen","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/cid\/ciz193","article-title":"Cryptococcus Infection Network Cohort Study Working Group. A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States","volume":"70","author":"Marr","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12281-019-00345-7","article-title":"Clinical Aspects of Immune Damage in Cryptococcosis","volume":"13","author":"Anjum","year":"2019","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e00588","DOI":"10.1016\/j.idcr.2019.e00588","article-title":"Cognitive biases and knowledge deficits leading to delayed recognition of cryptococcal meningitis","volume":"18","author":"Deming","year":"2019","journal-title":"IDCases"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3201\/eid2001.130906","article-title":"Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast","volume":"20","author":"Boulware","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e01238-18","DOI":"10.1128\/JCM.01238-18","article-title":"Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing","volume":"57","author":"Rajasingham","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e01563-20","DOI":"10.1128\/JCM.01563-20","article-title":"Performance of the Lateral Flow Assay and the Latex Agglutination Serum Cryptococcal Antigen Test in Cryptococcal Disease in Patients with and without HIV","volume":"58","author":"Hevey","year":"2020","journal-title":"J. Clin. Micro"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/2231-0770.114121","article-title":"Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases","volume":"3","author":"Ahmad","year":"2013","journal-title":"Avicenna J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1651-2227.1994.tb13140.x","article-title":"Hyper-IgM immunodeficiency with disseminated cryptococcosis","volume":"83","author":"Iseki","year":"1994","journal-title":"Acta Paediatr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hu, X.P., Wu, J.Q., Zhu, L.P., Wang, X., Xu, B., Wang, R.Y., Ou, X.T., and Weng, X.H. (2012). Association of Fcgamma receptor IIB polymorphism with cryptococcal meningitis in HIV-uninfected Chinese patients. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042439"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12931-022-02103-9","article-title":"Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis","volume":"23","author":"Salvator","year":"2022","journal-title":"Respir. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis","volume":"301","author":"Bennett","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJM198708063170602","article-title":"Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks","volume":"317","author":"Dismukes","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"994396","DOI":"10.3389\/fneur.2022.994396","article-title":"Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of post-infectious inflammatory response syndrome","volume":"13","author":"Ssebambulidde","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cid\/ciw305","article-title":"Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses","volume":"63","author":"Thompson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis","volume":"30","author":"Graybill","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/QCO.0000000000000315","article-title":"Repeated therapeutic lumbar punctures in cryptococcal meningitis\u2013necessity and\/or opportunity?","volume":"29","author":"Chang","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Panackal, A.A., Wuest, S.C., Lin, Y.C., Wu, T., Zhang, N., Kosa, P., Komori, M., Blake, A., Browne, S.K., and Rosen, L.B. (2015). Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004884"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fimmu.2018.00651","article-title":"Immunology of Cryptococcal Infections: Developing a Rational Approach to Patient Therapy","volume":"9","author":"Elsegeiny","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/cid\/ciw739","article-title":"Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults","volume":"64","author":"Panackal","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"18442","DOI":"10.1038\/s41598-019-54876-7","article-title":"HIV-Negative Cryptococcal Meningoencephalitis Results in a Persistent Frontal-Subcortical Syndrome","volume":"9","author":"Traino","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1038\/s41598-021-83176-2","article-title":"Quality of life of HIV-negative, previously healthy individuals following cryptococcal meningoencephalitis","volume":"11","author":"Dean","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/WNO.0000000000001713","article-title":"Ocular Findings of Cryptococcal Meningitis in Previously Healthy Adults","volume":"43","author":"Okeagu","year":"2023","journal-title":"J. Neuroophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/jnnp-2017-315830","article-title":"Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis","volume":"89","author":"Mehta","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e2789","DOI":"10.1093\/cid\/ciaa1901","article-title":"Outcomes in Previously Healthy Cryptococcal Meningoencephalitis Patients Treated with Pulse Taper Corticosteroids for Post-infectious Inflammatory Syndrome","volume":"73","author":"Anjum","year":"2021","journal-title":"Clin. Infect. Dis."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/11\/1303\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:14:42Z","timestamp":1760130882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/11\/1303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["pathogens12111303"],"URL":"https:\/\/doi.org\/10.3390\/pathogens12111303","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]}}}